Author:
To Kenneth K. W.,Cheung Ka M.,Cho William C. S.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference46 articles.
1. Alseksek RK, Ramadan WS, Saleh E, El-Awady R (2022) The role of HDACs in the response of cancer cells to cellular stress and the potential for therapeutic intervention. Int J Mol Sci 23:8141
2. Amelio I, Gostev M, Knight RA, Willis AE, Melino G, Antonov AV (2014) DRUGSURV: a resource for repositioning of approved and experimental drugs in oncology based on patient survival information. Cell Death Dis 5(2):e1051
3. Balasubramaniam S, Redon CE, Peer CJ, Bryla C, Lee MJ, Trepel JB, Tomita Y, Rajan A, Giaccone G, Bonner WM, Figg WD, Fojo T, Piekarz RL, Bates SE (2018) Phase I trial of belinostat with cisplatin and etoposide in advanced solid tumors, with a focus on neuroendocrine and small cell cancers of the lung. Anticancer Drugs 29(5):457–465
4. Basseville A, Violet PC, Safari M, Sourbier C, Linehan WM, Robey RW, Levine M, Sackett DL, Bates SE (2022) A histone deacetylase inhibitor induces acetyl-coA depletion leading to lethal metabolic stress in RAS-pathway activated cells. Cancers (basel) 14:2643
5. Bean GR, Ganesan YT, Dong Y, Takeda S, Liu H, Chan PM, Huang Y, Chodosh LA, Zambetti GP, Hsieh JJ, Cheng EH (2013) PUMA and BIM are required for oncogene inactivation-induced apoptosis. Sci Signal 6(268):ra20
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献